The content on this site is intended for healthcare professionals only
Eribulin and EMBRACE Study: focus on efficacy, side effect management and patient selection
Eribulin and EMBRACE Study: focus on efficacy and discussion regarding other studies underway and being planned with Eribulin.
The Cancer Genome Atlas (TCGA)
Role of adipose tissue in cancer proliferation
Full genome sequencing of 50 breast cancer patients
Breast milk analysis may offer early cancer test
AACR 2011: New Phase I targeted cancer drugs
Breast milk may provide a personalised screen of breast cancer risk
Study confirms genetic differences in breast tissue among races
Serendipity of cancer science & programme highlights (3/5)
Eribulin shows promise in phase-III trial
Access to new tailored cancer therapies and reliable patient information - the challenges
